Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s94, 2020. DOI: 10.25251/skin.4.supp.94. Disponível em: https://skin.dermsquared.com/skin/article/view/1064. Acesso em: 8 jun. 2025.